alphaveAPOLLOHOSP₹8,894.00

Apollo Hospitals Enterprise Ltd.

₹ CrorePeersFORTIS MAXHEALTH MEDANTA SUNPHARMA CIPLA DRREDDY DIVISLAB TORNTPHARMMcap ₹1.28L Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	8,540.5	9,815.7	11,038.6	11,038.6
+ Capital Work-in-Progress	844.7	771.0	991.5	991.5
+ Investment Property	3.4	2.8	2.2	2.2
+ Goodwill	1,012.3	1,030.5	1,032.3	1,032.3
+ Other Intangibles	107.7	139.2	198.5	198.5
+ Intangibles under Development	28.1	150.0	40.9	40.9
+ Investments (Equity Method)	198.4	224.1	256.4	256.4
+ Non-current Investments	103.7	830.4	905.8	905.8
+ Long-term Loans	6.6	27.2	15.6	15.6
+ Other Non-current Financial Assets	252.5	212.6	549.1	549.1
Non-current Financial Assets	362.8	1,070.2	1,470.5	1,470.5
+ Deferred Tax Assets	10.9	13.1	14.1	14.1
+ Other Non-current Assets	364.6	411.9	252.1	252.1
Total Non-current Assets	11,473.4	13,628.5	15,297.1	15,297.1
Current Assets
+ Inventories	459.8	480.8	542.4	542.4
+ Current Investments	684.0	1,432.3	1,016.5	1,016.5
+ Trade Receivables	2,514.9	3,016.1	3,484.9	3,484.9
+ Cash & Cash Equivalents	505.5	578.1	811.3	811.3
+ Other Bank Balances	428.3	782.1	305.5	305.5
+ Short-term Loans	4.9	5.1	2.4	2.4
+ Other Current Financial Assets	165.9	182.2	736.8	736.8
Current Financial Assets	4,303.5	5,995.9	6,357.4	6,357.4
+ Other Current Assets	516.4	552.2	342.0	342.0
Total Current Assets	5,279.7	7,028.9	6,899.8	6,899.8
Total Assets	16,753.1	20,657.4	22,196.9	22,196.9
Equity
+ Equity Share Capital	71.9	71.9	71.9	71.9
+ Other Equity / Reserves	6,863.5	8,140.4	9,408.2	9,408.2
Equity — Owners of Parent	6,935.4	8,212.3	9,480.1	9,480.1
+ Minority Interest	385.1	440.6	494.4	494.4
Total Equity	7,320.5	8,652.9	9,974.5	9,974.5
Liabilities
+ Borrowings — Non-current	2,235.6	4,417.0	2,430.1	2,430.1
+ Other Non-current Financial Liab	1,991.8	2,445.2	2,700.3	2,700.3
Non-current Financial Liabilities	4,227.4	6,862.2	5,130.4	5,130.4
+ Provisions — Non-current	73.2	88.6	99.5	99.5
+ Deferred Tax Liabilities	449.8	458.0	498.2	498.2
+ Other Non-current Liabilities	17.7	16.8	13.0	13.0
Non-current Liabilities	4,768.1	7,425.6	5,741.1	5,741.1
+ Borrowings — Current	926.3	858.2	3,228.4	3,228.4
+ Trade Payables	2,368.5	2,240.5	2,251.8	2,251.8
+ Other Current Financial Liab	988.1	1,035.0	495.1	495.1
Current Financial Liabilities	4,282.9	4,133.7	5,975.3	5,975.3
+ Provisions — Current	143.4	179.3	195.3	195.3
+ Current Tax Liabilities	1.3	1.6	2.6	2.6
+ Other Current Liabilities	236.9	264.3	308.1	308.1
Current Liabilities	4,664.5	4,578.9	6,481.3	6,481.3
Total Liabilities	9,432.6	12,004.5	12,222.4	12,222.4
Total Equity & Liabilities	16,753.1	20,657.4	22,196.9	22,196.9
Assets — additional as-filed lines
+ Current Tax Assets	242.4	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	84.8	80.8	122.6	122.6
+ Dues to Other Creditors — Current	—	2,159.7	2,129.2	2,129.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.